latest news releases from the newsroom
BSD Medical Corporation
BSD Medical Receives FDA Approval to Investigate New Cancer Treatment Applicator
SALT LAKE CITY, Utah, May 11, 2004 (PRIMEZONE) -- BSD Medical Corp. (OTCBB:BSDM) today announced that the FDA has granted BSD an investigational device exemption (IDE) approval for a new applicator used with the BSD-2000 Regional Hyperthermia System. The new applicator, called the "Sigma Ellipse", uses an array of antennae surrounding the patient to focus microwave energy on cancerous tissues located deep in the body -- such as ovarian, prostate, bladder, cervical and colon cancers -- and raise them to fever-level temperatures. The patient lies in a prone position and the applicator can be moved along the patient's body to the ideal position for focusing on the cancer.
New IBM eServer BladeCenter Server Blades Incorporate QLogic Fibre Down and Embedded Switching
ALISO VIEJO, Calif., May 11, 2004 (PRIMEZONE) -- QLogic Corp. (Nasdaq:QLGC), the company that powers storage area networks (SANs), today announced that its switch blades, management controllers and Fibre Down(tm) host bus adapters are shipping with the new IBM eServer BladeCenter JS20 server blade, the industry's first blade server based on the POWER Architecture and the new IBM eServer BladeCenter HS40 server blade, a 4-way Intel(r) processor-based server. QLogic has been shipping storage connectivity components for BladeCenter and BladeCenter T systems for more than a year, including six HS20 2-way Intel processor based models.
ViroPharma Appoints Colin Broom, M.D. Vice President and Chief Scientific Officer
EXTON, Pa., May 11, 2004 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) announced today that Colin Broom, M.D. has joined the company as vice president and chief scientific officer. Dr. Broom will be responsible for the leadership of all product development activities and will play a key role in the company's strategic business development efforts. Most recently, he served as vice president of clinical development and medical affairs, Amgen Europe. Prior to this, he was senior vice president of global clinical development for Hoechst Marion Roussel (now Aventis) and vice president, clinical development, North America at SmithKline Beecham (now GlaxoSmithKline).
iMedia International, Inc.
iMedia International, Inc. Completes Funding Round with Augustine Fund, LP
SANTA MONICA, Calif., May 11, 2004 (PRIMEZONE) -- iMedia International, Inc. (the "Company") (Pink Sheets:IMNL), pioneers in the interactive digital multimedia publishing industry, announces the successful completion of US$250,000.00 in funding with Augustine Fund, LP.
Cycle Country Reports Superior 2nd Quarter Results:
MILFORD, Iowa, May 11, 2004 (PRIMEZONE) -- Cycle Country Accessories Corp. (AMEX:ATC), the recognized leader in developing and manufacturing a variety of products for all-terrain vehicles (ATVs), garden tractors, and golf carts, reported record results for the second quarter of fiscal 2004.
Board convenes an Extraordinary General Meeting on June 16, 2004 for implementation of the share redemption offer
STOCKHOLM, Sweden, May 11, 2004 (PRIMEZONE) -- (ELUX) The Annual General Meeting on April 21, 2004 resolved on a share redemption offer to the shareholders of Electrolux. The application period for the redemption offer runs for the period May 4 -- June 1, 2004. The Board of Directors of Electrolux has today decided to convene an Extraordinary General Meeting to be held on June 16, 2004, at which the shareholders are proposed to adopt the resolutions required for implementation of the redemption offer.